Sort   by:  
 Page size 
ProteomicsApolipoprotein A-II Increases Cholesterol Efflux Capacity of Mature High-Density Lipoproteins Via the Apolipoprotein A-I C-terminus
Samples were processed using Global and Limited Proteolysis (LiP). Peptides and proteins were identified using MaxQuant (v1.6.17.0), then summarized using R package RomicsProcessor.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2024-07-29 | MSV000095479 | MassIVE
UnknownEffects of intensive blood-pressure control in type 2 diabetes mellitus.
Not available
S-EPMC4123215 | biostudies-literature
UnknownLong-term effects of intensive glucose lowering on cardiovascular outcomes.
Not available
S-EPMC4083508 | biostudies-literature
UnknownEffects of combination lipid therapy in type 2 diabetes mellitus.
Not available
S-EPMC2879499 | biostudies-literature
UnknownThiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276 | biostudies-literature
UnknownSporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4301065 | biostudies-literature
UnknownSubretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4549177 | biostudies-literature
UnknownAngiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4808340 | biostudies-literature
UnknownMacular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC3737287 | biostudies-literature
UnknownRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Not available
S-EPMC3389193 | biostudies-literature
Sort   by:  
 Page size